A proposal for the repositioning of prophylactic breast radiotherapy of prostate cancer patients

Future Oncology

Volumn 1, Issue 5, 2005, Pages 625-629

  Ochel, Hans Joachim ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

anti androgen; gynecomastia; mammalgia

Indexed keywords

EID: 33846227500     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/14796694.1.5.625     Document Type: Article

References (14)

1. Pilepich MV, Winter K, John MJ et al.: Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate. Int. J. Radiat. Oncol. Biol. Phys. 50, 1243-1252 (2001
2. Pilepich MV, Caplan R, Byhardt RW et al.: Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31. J. Clin. Oncol. 15, 1013-1021 (1997
3. Kirschenbaum A: Mangement of hormonal treatment effects. Cancer 75, 1983-1986 (1995
4. Larsson LG, Sundbom CM: Roentgen irradiation of the male breast. Acta Radiol. 58, 253 (1962
5. Alfthan O, Holsti LR: Prevention of gynecomastia by local roentgen irradiation in estrogen-treated prostatic carcinoma. Scand. J. Urol. Nephrol. 3, 183-187 (1969
6. Tyrrell CJ, Payne H, Tammela TLJ et al.: Prophylactic breast irradiation with a single dose of electron beam radiotherapy (10 Gy) significantly reduces the incidence of bicalutamide-induced gynecomastia. Int. J. Radiat. Oncol. Biol. Phys. 60, 476-483 (2004
7. Boccardo F, Rubagotti A, Battaglia M et al.: Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer. J. Clin. Oncol. 23, 808-815 (2005
8. Perdona S, Autorino R, De Placido S et al.: Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynecomastia and breast pain caused by bicalutamide in prostate cancer: a randomized trial. Lancet Oncol. 6, 295-300 (2005
9. Dicker AP: The safety and tolerability of lowdose irradiation for the management of gynaecomastia caused by anti-androgen monotherapy. Lancet Oncol. 4, 30-36 (2003
10. Anelli TF, Anelli A, Tran KN, Lebwohl DE, Borgen PI: Tamoxifen administration is associated with a high rate of treatmentlimiting symptoms in male breast cancer. Cancer 74, 74-77 (1994
11. See WA, Wirth MP, McLeod DG et al.: Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: first analysis of the early prostate cancer program. J. Urol. 168, 429-435 (2002
12. Alfthan O, Kettunen K: The effect of roentgen ray treatment of gynecomastia in patients with prostatic carcinoma treated with estrogenic hormones: a preliminary communication. J. Urol. 94, 604-606 (1965
13. McLeod DG, Iversen P: Gynecomastia in patients with prostate cancer: a review of treatment options. Urology 56, 713-720 (2000
14. Chou JL, Easley JD, Feldmeier JJ, Rauth VA, Pomeroy DC: Effective radiotherapy in palliating mammalgia associated with gynecomastia after DES therapy. Int. J. Radiat Oncol. Biol. Phys. 15, 749-751 (1988